Article
Robust human genetic evidence supporting causal effects of FGF21 on reducing alcohol consuming behaviours.
BMC medicine - 23 Mar 2026
Cronjé Héléne T, Hu Sile, Gurrell Rachel, Vujkovic Marijana, Larsson Susanna C, Mason Richard, Butt Richard, Gill Dipender
Abstract excerpt
BACKGROUND: Alcohol use disorder (AUD) represents a tremendous societal burden, yet few efficacious therapies are available and widely used. Pre-clinical and human observational data support fibroblast growth factor 21 (FGF21) as a promising therapeutic target for the treatment of AUD. The objective of this study is to identify a robust genetic instrument for FGF21 agonism and leverage it to explore the effects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
